ALGERNON NEUROSCIENCE

Algernon NeuroScience is a wholly owned private subsidiary of Algernon Pharmaceuticals and has been established to advance its psychedelic DMT program for stroke and traumatic brain injury (TBI)... Algernon Pharmaceuticals is a clinical stage, Canadian drug development and repurposing company investigating multiple drugs for unmet global medical needs. In addition to the psychedelic DMT program for stroke and traumatic brain injury recovery being run by Algernon NeuroScience, Algernon Pharmaceuticals is also investigating Ifenprodil for chronic cough and idiopathic pulmonary fibrosis, as well as Repirinast for chronic kidney disease.

Primary location: Vancouver